In September, two publications on the AGMT_MM-1 study were published....
The aim of this conference is an in depth discussion with international leaders focusing on tumor immunology, immunogenicity of breast cancer as well as on current and new strategies in immunotherapy for this disease.
The successful events of the last years confirmed our intention to create a platform in breast cancer immunotherapy and research that will enable rapid and efficient translation of preclinical research into clinical development.
The reputation of the event is underlined not only by the commitments of international keynote speakers but also by the recommendation of the European CanCer Organisation (ECCO). With 23 member societies – represented by more than 150,000 experts – it is the only multidisciplinary organisation that links all oncology interest groups throughout Europe.